Trevena Inc (TRVN)
1.765
+0.08
(+4.44%)
USD |
OTCM |
Nov 05, 10:46
Trevena Debt to Equity Ratio: -1.663 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.663 |
| March 31, 2024 | -2.137 |
| December 31, 2023 | -4.024 |
| September 30, 2023 | 8.352 |
| June 30, 2023 | 1.449 |
| March 31, 2023 | 1.327 |
| December 31, 2022 | 0.861 |
| September 30, 2022 | 0.619 |
| June 30, 2022 | 0.3748 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.1675 |
| September 30, 2019 | 0.2359 |
| June 30, 2019 | 0.2656 |
| March 31, 2019 | 0.3089 |
| December 31, 2018 | 0.4184 |
| September 30, 2018 | 0.419 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.6039 |
| March 31, 2018 | 0.6899 |
| December 31, 2017 | 0.8128 |
| September 30, 2017 | 0.5996 |
| June 30, 2017 | 0.5033 |
| March 31, 2017 | 0.4147 |
| December 31, 2016 | 0.233 |
| September 30, 2016 | 0.1972 |
| June 30, 2016 | 0.1508 |
| March 31, 2016 | 0.1314 |
| December 31, 2015 | 0.1271 |
| September 30, 2015 | 0.0113 |
| June 30, 2015 | 0.0189 |
| March 31, 2015 | 0.0197 |
| December 31, 2014 | 0.0171 |
| September 30, 2014 | 0.0276 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | |
| December 31, 2012 | -124.25 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.024
Minimum
Dec 2023
8.352
Maximum
Sep 2023
0.2804
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7831 |
| United Therapeutics Corp | 0.0656 |
| Syndax Pharmaceuticals Inc | 0.00 |
| Arcus Biosciences Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -1.128 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 22.94M |
| Total Liabilities (Quarterly) | 41.90M |
| Shareholders Equity (Quarterly) | -18.96M |
| Current Ratio | 3.464 |
| Net Debt Paydown Yield | -77.67% |